Literature DB >> 10685329

Does female age affect embryo morphology?

I Bar-Hava1, A Ferber, J Ashkenazi, R Orvieto, B Kaplan, J Bar, D Peleg, Z Ben-Rafael.   

Abstract

Deteriorating oocyte quality is commonly believed to be the primary determinant of the decreased implantation potential in older women. We assessed the influence of age on embryo morphology in standard in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) modalities. All 6350 consecutive embryos (2990 IVF, 3360 ICSI) obtained in our Assisted Reproductive Technology Unit from January 1996 through June 1997 were included. High quality embryos were defined as those with equal-sized blastomeres and < 10% fragmentations and a cleavage rate of four cells on day 2 or eight cells on day 3 transfers. The results were analyzed for the standard IVF group, the ICSI group, and the ICSI subgroup with severe male factor infertility (< or = 1 x 10(6) total motile spermatozoa in the ejaculate). For standard IVF, a positive association was observed between female age and increased proportion of good quality embryos. No such association was detected for the ICSI cycles (whole group or subgroup). We conclude that in standard IVF, embryo quality, as reflected by embryo morphology, does not deteriorate with increased maternal age.

Entities:  

Mesh:

Year:  1999        PMID: 10685329     DOI: 10.3109/09513599909167582

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  2 in total

1.  The Effect of Advanced Maternal Age on Embryo Morphokinetics.

Authors:  Miriam Warshaviak; Yael Kalma; Ariela Carmon; Nivin Samara; Michal Dviri; Foad Azem; Dalit Ben-Yosef
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-25       Impact factor: 5.555

2.  Comparisons of the effects of long-acting and short-acting GnRH agonists on embryo quality, endometrial thickness and pregnancy rate in human in vitro fertilization.

Authors:  Gen-Hong Mao; Zonggang Feng; Yan He; Yu-Rong Huang
Journal:  Arch Med Sci       Date:  2014-02-23       Impact factor: 3.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.